BioSpace - Financial Content

Symbol 'IRBO' could not be found. Search For:

Thu, Jul 17, 2008
	ImmuneRegen(R) BioSciences Advances Toward IND Filing Homspera(R) Clears Initial Toxicity Hurdle - Business Wire
Mon, Jun 16, 2008
	Biotech Experts Available to Discuss the Critical Role of Vaccine Adjuvants in Treating Pandemic Bird Flu - Business Wire
Mon, Jun 09, 2008
	ImmuneRegen(R) BioSciences Confirms Adult Stem Cell Activity of Homspera(R) in Human Bone Marrow Tests from an Additional Multi-Donor Study Further Substantiate Previous Adult Stem Cell Findings - Business Wire
Tue, May 20, 2008
	ImmuneRegen(R) Announces Preliminary Results on Dermatological Testing: Homspera(R) Accelerates Wound Healing in vivo and Shows Immune Enhancing Activity on Subcutaneous Administration Company Extends Findings in Support of Licensure for Skin Applications - Business Wire
Tue, May 06, 2008
	ImmuneRegen(R) Appoints Renowned Hematologist Ivan N. Rich, Ph.D. to Advisory Board Company Gains Further Expertise to Support Corporate Growth and Commercialization of Adult Stem Cell Compound - Business Wire
More Press Releases

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Daily Market Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs